13F HOLDINGS REPORT
Lunate Capital Ltd
Quarter ended Q4 2025 · Filed January 23, 2026 · Accession 0001011438-26-000036
Total Value
$264.3M
Positions
6
Other Managers
1
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMDW | 2,196,200 | $174.9M | 66.20% |
| 2 | SAILPOINT INC | SAIL | 3,000,000 | $60.7M | 22.97% |
| 3 | LINEAGE INC | LINE | 600,000 | $21.0M | 7.95% |
| 4 | NEUMORA THERAPEUTICS INC. | NMRA | 2,124,143 | $3.8M | 1.44% |
| 5 | NAVAN INC | NAVN | 200,000 | $3.4M | 1.29% |
| 6 | REVOLUTION MEDICINES INC | RVMDW | 450,000 | $422,955 | 0.16% |